Can exercise, diet, or a pill help older diabetics stay strong?
NCT ID NCT03560375
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study looked at three ways to help people aged 65 and older with type 2 diabetes improve their physical and metabolic health. One group did home-based circuit resistance training, another followed a plant-based Mediterranean diet, and the third took the diabetes drug empagliflozin. After 10 weeks, the diet and drug groups also started exercising. The goal was to see if these approaches could improve body composition, muscle strength, and blood sugar control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
empagliflozin
What this could lead to
If successful, this could show that simple lifestyle changes or a common diabetes drug help older adults with diabetes maintain muscle strength and control blood sugar.
What could go wrong
This is a small, completed trial with 100 participants, so results may not apply to everyone. The interventions are short-term (10-20 weeks), so long-term benefits or risks are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Institute of Endocrinology Metabolism and Hypertension
Tel Aviv, 64239, Israel